Zhejiang Xinguang Pharmaceutical Co Ltd (300519) - Total Liabilities
Based on the latest financial reports, Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has total liabilities worth CN¥65.46 Million CNY (≈ $9.58 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Zhejiang Xinguang Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Zhejiang Xinguang Pharmaceutical Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Zhejiang Xinguang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Zhejiang Xinguang Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Zhejiang Xinguang Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Xinguang Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Eventbrite Inc Class A
NYSE:EB
|
USA | $555.47 Million |
|
Home Invest Belgium - Sifi
BR:HOMI
|
Belgium | €471.46 Million |
|
Patrimoine et Commerce SA
PA:PAT
|
France | €490.80 Million |
|
Source Capital Closed Fund
NYSE:SOR
|
USA | $1.12 Million |
|
Guangzhou Jointas Chemical Joint Stock Co Ltd
SHE:002909
|
China | CN¥1.35 Billion |
|
Coca-Cola Europacific Partners PLC
LSE:CCEP
|
UK | GBX21.56 Billion |
|
MCBC Holdings Inc
NASDAQ:MCFT
|
USA | $70.42 Million |
|
Raisio Oyj Vaihto-osake
HE:RAIVV
|
Finland | €68.20 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Zhejiang Xinguang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300519 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Xinguang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual total liabilities of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥79.25 Million ≈ $11.60 Million |
-8.15% |
| 2023-12-31 | CN¥86.29 Million ≈ $12.63 Million |
-12.72% |
| 2022-12-31 | CN¥98.86 Million ≈ $14.47 Million |
+14.71% |
| 2021-12-31 | CN¥86.19 Million ≈ $12.61 Million |
+35.00% |
| 2020-12-31 | CN¥63.84 Million ≈ $9.34 Million |
+3.94% |
| 2019-12-31 | CN¥61.42 Million ≈ $8.99 Million |
-11.29% |
| 2018-12-31 | CN¥69.24 Million ≈ $10.13 Million |
+0.00% |
| 2017-12-31 | CN¥69.24 Million ≈ $10.13 Million |
+14.47% |
| 2016-12-31 | CN¥60.49 Million ≈ $8.85 Million |
+13.02% |
| 2015-12-31 | CN¥53.52 Million ≈ $7.83 Million |
-1.07% |
| 2014-12-31 | CN¥54.10 Million ≈ $7.92 Million |
+22.14% |
| 2013-12-31 | CN¥44.29 Million ≈ $6.48 Million |
-41.58% |
| 2012-12-31 | CN¥75.82 Million ≈ $11.09 Million |
-34.09% |
| 2011-12-31 | CN¥115.03 Million ≈ $16.83 Million |
-- |
About Zhejiang Xinguang Pharmaceutical Co Ltd
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquar… Read more